Testosteron Cypionate liquid 200mg/ml, RX, glass vial

FDA Drug Recall #D-0401-2019 — Class II — January 2, 2019

Recall Summary

Recall Number D-0401-2019
Classification Class II — Moderate risk
Date Initiated January 2, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
Location Roseburg, OR
Product Type Drugs
Quantity 200 ml

Product Description

Testosteron Cypionate liquid 200mg/ml, RX, glass vial

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.

Lot / Code Information

10012018@54 exp 3/30/19

Other Recalls from Hiers Enterprises, LLC dba Northwest ...

Recall # Classification Product Date
D-0400-2019 Class II Methocarbamol liquid 100mg/ml, RX, glass vial Jan 2, 2019
D-0397-2019 Class II Lidocaine gel 2%, RX, plastic dropper Jan 2, 2019
D-0396-2019 Class II Hydroxyprogesterone liquid, 250mg/ml, RX, glass... Jan 2, 2019
D-0407-2019 Class II Glutathione liquid, 200mg/ml, Rx Jan 2, 2019
D-0399-2019 Class II MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX gla... Jan 2, 2019

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.